skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

もっと見る

Products

もっと見る

もっと見る

99+ Total results for product and free and sample content found

世界の薬事規制動向&情報を配信

US FDA Advisory Committees Could Get Revamp With A Focus On Science Over Emotion

PS2106_emotionsonrocks_2A6FBP5_1200

CDER Director Cavazzoni also wants to loosen conflict of interest rules and improve technology for remote meetings. Given FDA’s approval of Aduhelm, her comments, made in a prerecorded interview for the BIO Digital annual meeting, may raise some eyebrows. Industry is also working on recommendations for the agency on the topic.

Generics Bulletin: ジェネリック&バイオシミラーニュース

Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

GB2106_Biden_Harris_2CD06C5_1200

After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.

Medtech Insight: 世界の医療機器・医療技術の最新情報

Netherland’s DEKRA Is Latest Notified Body Designated Under EU IVDR

netherlands_flag_606897284_1200px

With most IVDs needing to be compliant with the EU’s new IVD Regulation by late May 2022, many more testing bodies are urgently needed. The designation process is limping along, but a fifth organization has been named at last.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Biogen/Sage’s Zuranolone Data May Not Be Enough For Tough Commercial Landscape

Depression_703104430_1200x675

The drug may have enough efficacy for approval, but data fell short of the benchmark seen as necessary for commercial adoption.

Medtech Insight: 世界の医療機器・医療技術の最新情報

StrataGraft Topical Burn Treatment Gets US FDA Approval

PS2101_FDAbuilding_1851631498_1200

The topical treatment is made from human skin cells and can be applied to speed the healing of deep thermal burns.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Novavax’s Latecomer COVID-19 Vaccine Impresses With 90% Efficacy Result

NovavaxFlag

Arriving two to three months later than planned, Novavax’s nanoparticle-based vaccine is still a welcome addition to the field, for both rich and poor countries.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Quick Listen: Scrip’s Five Must-Know Things

SC2008_FiveMustKnowThings_1200_Final

In this week's podcast edition of Five Must-Know Things: a ground-breaking approval for Alzheimer’s in the US; LAG-3 inhibitors and new Keytruda data generate excitement at ASCO; and clinical progress for another COVID-19 vaccine.

HBW Insight : コンシューマーヘルスケア産業のニュース

Bayer Leads Push For Self-Care In India As Local Business Launches

BayerHeadquarters_1549291172_1200

Bayer has launched a dedicated Consumer Health business in India to market products in key OTC categories. The company is also working to bring different stakeholders together through the creation of a new organization dedicated to promoting self-care in the South Asian country.

HBW Insight : コンシューマーヘルスケア産業のニュース

New York’s Age Restrictions On Weight Loss, Sports Supplement Sales Fail To Fly

Legislative_process

New York legislation to restrict sales of weight loss and sports nutrition supplements to minors failed without reaching a vote before the end of the session. But the proposal will continue to be a challenge for industry in New York as well as around the country.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。

Eメール:inquiry.jp@informa.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。